Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea. [electronic resource]
Producer: 20170620Description: 365-374 p. digitalISSN:- 1572-0241
- Abdominal Pain -- chemically induced
- Adult
- Aged
- Constipation -- chemically induced
- Diarrhea -- drug therapy
- Double-Blind Method
- Female
- Gastrointestinal Agents -- adverse effects
- Humans
- Imidazoles -- adverse effects
- Irritable Bowel Syndrome -- complications
- Male
- Middle Aged
- Nausea -- chemically induced
- Pancreatitis -- chemically induced
- Phenylalanine -- adverse effects
- Receptors, Opioid, delta -- antagonists & inhibitors
- Receptors, Opioid, kappa -- agonists
- Receptors, Opioid, mu -- agonists
- Spasm -- chemically induced
- Sphincter of Oddi Dysfunction -- chemically induced
No physical items for this record
Publication Type: Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.